Dietary zinc intake is associated with macular fluid in neovascular age-related macular degeneration

被引:10
|
作者
Dharamdasani Detaram, Harshil [1 ,2 ]
Mitchell, Paul [1 ,2 ]
Russell, Joanna [3 ]
Burlutsky, George [1 ,2 ]
Liew, Gerald [1 ,2 ]
Gopinath, Bamini [1 ,2 ]
机构
[1] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia
[2] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia
[3] Univ Wollongong, Sch Hlth & Soc, Fac Social Sci, Sydney, NSW, Australia
关键词
age-related macular degeneration; epidemiology; micronutrient; CLINICAL-TRIAL; VISUAL-ACUITY; ORAL ZINC; SUPPLEMENTATION; RANIBIZUMAB; THICKNESS;
D O I
10.1111/ceo.13644
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Importance Numerous dietary factors have been shown to reduce progression from early to late age-related macular degeneration (AMD), however, little is known on their impact in patients diagnosed with late-stage disease. Background To determine whether a dietary intake high in antioxidants and zinc, fruits, vegetables and fish is associated with favourable clinical outcomes in patients with neovascular AMD (nAMD) undergoing anti-vascular endothelial growth factor therapy. Design Cross-sectional study carried out at a private ophthalmology clinic. Participants Five hundred forty-seven participants with nAMD. Methods Diet was determined using a validated food frequency questionnaire. Presence of intra-retinal and sub-retinal fluid (IRF, SRF), pigment epithelial detachment and central macular thickness (CMT) were recorded from ocular coherence tomography images. Main Outcome Measures Fluid presence, mean CMT and visual acuity. Results Participants with daily zinc intake below (n = 91) vs above (n = 333) 8.1 mg had greater odds of SRF being present, multivariable-adjusted odds ratio (OR) of 0.56 (95% CI 0.36-0.96). This association was stronger in persons with at least 6 months of treatment, OR of 0.32 (95% CI 0.14-0.75). In the entire cohort, participants in the lowest or first quartile compared to those in the upper three quartiles of zinc intake combined had significantly greater mean CMT (254.81 mu m vs 232.15 mu m, respectively, multivariable-adjusted P = .03). Conclusions and Relevance Low dietary zinc intake was associated with a greater likelihood of SRF presence, particularly in those treated for at least 6 months, and increased macular thickness in treated eyes with nAMD.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 50 条
  • [21] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [22] Characteristics of Neovascular Age-Related Macular Degeneration in Brazilian Patients
    Pereira, Frederico Braga
    Veloso, Carlos Eduardo
    Kokame, Gregg T.
    Nehemy, Marcio B.
    OPHTHALMOLOGICA, 2015, 234 (04) : 233 - 242
  • [23] Levodopa Is Associated with Reduced Development of Neovascular Age-Related Macular Degeneration
    Hyman, Max J.
    Skondra, Dimitra
    Aggarwal, Nitika
    Moir, John
    Boucher, Nick
    Mckay, Brian S.
    Maccumber, Mathew W.
    Lavine, Jeremy A.
    OPHTHALMOLOGY RETINA, 2023, 7 (09): : 745 - 752
  • [24] MACULAR HEMORRHAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AFTER STABILIZATION WITH ANTIANGIOGENIC THERAPY
    Levine, Jonathan P.
    Marcus, Inna
    Sorenson, John A.
    Spaide, Richard F.
    Cooney, Michael J.
    Freund, K. Bailey
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (08): : 1074 - 1079
  • [25] Hot Topics in Pharmacotherapy for Neovascular Age-Related Macular Degeneration
    Falavarjani, Khalil Ghasemi
    Sadda, Srinivas R.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (04) : 535 - 541
  • [26] Therapeutic effects of ranibizumab in neovascular age-related macular degeneration
    Ciulla, Thomas A.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (05) : 679 - 693
  • [27] Review of Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration
    Stewart, Michael W.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 81 - 93
  • [28] RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kaiser, Peter K.
    Wykoff, Charles C.
    Singh, Rishi P.
    Khanani, Arshad M.
    Do, Diana V.
    Patel, Hersh
    Patel, Nikhil
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (08): : 1579 - 1586
  • [29] The effect of topical bromfenac on intraretinal and subretinal fluid in neovascular age-related macular degeneration
    Abdolrahimzadeh, Solmaz
    Fameli, Valeria
    Di Tizio, Federico
    Di Staso, Federico
    Fenicia, Vito
    Scuderi, Gianluca
    JOURNAL OF CURRENT OPHTHALMOLOGY, 2020, 32 (02): : 203 - 206
  • [30] Intravitreal conbercept injection for neovascular age-related macular degeneration
    Wu, Bing-Hui
    Wang, Bing
    Wu, Hui-Qin
    Chang, Qin
    Lu, Hui-Qin
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2019, 12 (02) : 252 - 257